Pharmacokinetic and pharmacodynamic alterations in older people with dementia-Reference-Cited by-同舟云学术

Pharmacokinetic and pharmacodynamic alterations in older people with dementia

Published:2017-05-10 Issue:6 Volume:13 Page:651-668
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Reeve Emily¹²^ORCID,Trenaman Shanna C³,Rockwood Kenneth²⁴⁵,Hilmer Sarah N¹⁶^ORCID

Affiliation:

1. NHMRC Cognitive Decline Partnership Centre, Kolling Institute of Medical Research, Northern Clinical School, Faculty of Medicine, University of Sydney, Sydney, Australia

2. Geriatric Medicine Research, Faculty of Medicine, Dalhousie University and Nova Scotia Health Authority, Halifax, NS, Canada

3. Dalhousie University and Nova Scotia Health Authority, Halifax, NS, Canada

4. Division of Geriatric Medicine, Dalhousie University, Halifax, NS, Canada

5. DGI Clinical Inc., Halifax, Canada

6. Departments of Aged Care and Clinical Pharmacology, Royal North Shore Hospital, St Leonards, NSW, Australia

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2017.1325873

Reference185 articles.

1. Prince M, Wimo A, Guerchet M, et al. World Alzheimer report 2015: the global impact of dementia - an analysis of prevalence, incidence, cost and trends. Alzheimer’s Dis Int. 2015. Available from: https://www.alz.co.uk/research/world-report-2015

2. Medical research: Treat ageing

3. Comorbidity Profile of Dementia Patients in Primary Care: Are They Sicker?

4. Co-morbidity and drug treatment in Alzheimer's disease. A cross sectional study of participants in the Dementia Study in Northern Norway

5. Polypharmacy and Potentially Inappropriate Medication Use Among Community-dwelling Elders With Dementia

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A need to integrate pharmacological management for multimorbidity into dementia guidelines in Australia;Frontiers in Public Health;2024-07-23

2. Adverse event profile of memantine and donepezil combination therapy: a real-world pharmacovigilance analysis based on FDA adverse event reporting system (FAERS) data from 2004 to 2023;Frontiers in Pharmacology;2024-07-17

3. Potentially inappropriate prescribing for people with dementia in ambulatory care: a cross-sectional observational study;BMC Geriatrics;2024-04-10

4. Drug Related Problems among Older Inpatients at a Tertiary Care Setting;Journal of Clinical Medicine;2024-03-13

5. Polypharmacy Is Associated with Sociodemographic Factors and Socioeconomic Status in United States Adults;Pharmacy;2024-03-12